Subtle Medical Raises Nearly $10M in Series B+ Round
Subtle Medical, a Menlo Park, CA-based AI-powered medical image acquisition, has raised of nearly $10 million in Series B+ funding.
Subtle Medical, a Menlo Park, CA-based AI-powered medical image acquisition, has raised of nearly $10 million in Series B+ funding.
Investors
The round includes participation from existing shareholders like Fusion Fund and prominent global investors, such as EnvisionX Capital, BRV Capital, Ignite Innovation, and Samsung Ventures. With this latest infusion, Subtle Medical's Series B funding now exceeds $30 million, bringing the total financing to over $50 million.
Subtle Medical Use of Funds
The company will use the funding to support accelerated US and global sales initiatives and to expedite the launch of new AI-driven products.
About Subtle Medical
Founded in 2017 by Dr. Enhao Gong and Dr. Greg Zaharchuk, Subtle Medical is a medical imaging software company that leverages AI and advanced generative models to enhance the data acquisition stage of medical imaging exams, including MRI, PET, CT, SPECT, and angiography. The company's cutting-edge solutions optimize imaging workflows and improve productivity and patient experience. Headquartered in Silicon Valley with a globally distributed team, Subtle Medical primarily offers AI solutions as SaaS or software systems to hospitals and imaging centers in the United States, Europe, and Latin America.
Funding Details
Company: Subtle Medical, Inc.
Raised: $10.0M
Round: Series B+
Funding Month: July 2024
Investors: Fusion Fund, EnvisionX Capital, BRV Capital, Ignite Innovation, Samsung Ventures
Company Website: https://subtlemedical.com/
Software Category: Medical Imaging
